Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 20, 10 Issues, 2021
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Manuscript Transfer Facility

If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.

Transfer of Submission

Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.

Step 1.

The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.

Step 2.

The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.

Step 3.

The Author then receives an editorial decision from the journal.

Selection of another Journal

The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.

Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog